Mesa Laboratories Stock-Based Compensation 2010-2024 | MLAB
Mesa Laboratories stock-based compensation from 2010 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| Mesa Laboratories Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $12 |
| 2023 | $13 |
| 2022 | $11 |
| 2021 | $9 |
| 2020 | $6 |
| 2019 | $4 |
| 2018 | $2 |
| 2017 | $1 |
| 2016 | $1 |
| 2015 | $1 |
| 2014 | $1 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.627B | $0.216B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||